Literature DB >> 21323965

Diagnosis of testicular carcinoma in situ '(intratubular and microinvasive)' seminoma and embryonal carcinoma using direct enzymatic alkaline phosphatase reactivity on frozen histological sections.

Hans Stoop1, Wim Kirkels, Gert R Dohle, Ad J M Gillis, Michael A den Bakker, Katharina Biermann, Wolter Oosterhuis, Leendert H J Looijenga.   

Abstract

AIMS: Testis-sparing surgery might benefit quality of life, but can only be applied with histological examination for the presence of invasive germ cell tumour components, and the precursor carcinoma in situ (CIS). Currently, diagnosis is based on paraffin-embedded tissue, therefore a delay in further surgery is mainly unavoidable. The aim was to develop an intraoperative assessment technique using alkaline phosphatase as a marker. METHODS AND
RESULTS: A total of 4093 snap-frozen samples and matched paraffin-embedded tissue of 1500 patients were included. Besides standard haematoxylin and eosin (H&E) staining, the direct enzymatic alkaline phosphatase reactivity (dAP) test (duration 15 min) was applied on frozen sections, while H&E and immunohistochemistry for detection of OCT3/4, α-fetoprotein, human chorionic gonadotrophin (hCG) and cytokeratin was performed on the paraffin-embedded slides. Endothelial cells served as control for the dAP test. Positive staining was found in all CIS (n=965), seminoma (n=1035) and embryonal carcinoma (n=584), either intratubular, microinvasive or invasive. Differentiated non-seminomas (n=1238) showed variable staining. No staining was identified in spermatocytic seminomas (n=5), testicular lymphomas (n=42), testicular rhabdomyosarcomas (n=7), Leydig cell tumours (n=31), Sertoli-cell-only nodules (n=4), (epi) dermoid cyst (n=16), normal testicular parenchyma (n=116), testicular torsion (n=32) and inflammation of the epididymis (n=19). The dAP test results matched H&E-stained parallel sections, as well paraffin-embedded tissue analysis, including immunohistochemistry.
CONCLUSIONS: The dAP test is an informative, reproducible and easy tool to diagnose CIS, (intratubular and microinvasive) seminoma and embryonal carcinoma on frozen tissue sections, being of great value in the context of sparing surgery.
© 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21323965     DOI: 10.1111/j.1365-2559.2011.03767.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

Review 1.  [Carcinoma in situ of the testis: predisposition, evolution and early detection].

Authors:  K Biermann
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

Review 2.  Testicular cancer: biology and biomarkers.

Authors:  Leendert H J Looijenga; Hans Stoop; Katharina Biermann
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

3.  Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test).

Authors:  Ton van Agthoven; Leendert H J Looijenga
Journal:  Oncotarget       Date:  2016-07-27

4.  Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development.

Authors:  Lambert C J Dorssers; Ad J M Gillis; Hans Stoop; Ronald van Marion; Marleen M Nieboer; Job van Riet; Harmen J G van de Werken; J Wolter Oosterhuis; Jeroen de Ridder; Leendert H J Looijenga
Journal:  Br J Cancer       Date:  2019-02-11       Impact factor: 7.640

Review 5.  Predicting Gonadal Germ Cell Cancer in People with Disorders of Sex Development; Insights from Developmental Biology.

Authors:  Leendert H J Looijenga; Chia-Sui Kao; Muhammad T Idrees
Journal:  Int J Mol Sci       Date:  2019-10-10       Impact factor: 5.923

6.  Comparing genome-scale DNA methylation and CNV marks between adult human cultured ITGA6+ testicular cells and seminomas to assess in vitro genomic stability.

Authors:  Robert B Struijk; Lambert C J Dorssers; Peter Henneman; Martin A Rijlaarsdam; Andrea Venema; Aldo Jongejan; Marcel M A M Mannens; Leendert H J Looijenga; Sjoerd Repping; Ans M M van Pelt
Journal:  PLoS One       Date:  2020-03-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.